Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:281556rdf:typepubmed:Citationlld:pubmed
pubmed-article:281556lifeskim:mentionsumls-concept:C1522424lld:lifeskim
pubmed-article:281556lifeskim:mentionsumls-concept:C0022688lld:lifeskim
pubmed-article:281556lifeskim:mentionsumls-concept:C0312418lld:lifeskim
pubmed-article:281556lifeskim:mentionsumls-concept:C1522021lld:lifeskim
pubmed-article:281556lifeskim:mentionsumls-concept:C0024348lld:lifeskim
pubmed-article:281556lifeskim:mentionsumls-concept:C1709059lld:lifeskim
pubmed-article:281556lifeskim:mentionsumls-concept:C1533691lld:lifeskim
pubmed-article:281556lifeskim:mentionsumls-concept:C0036667lld:lifeskim
pubmed-article:281556pubmed:issue6lld:pubmed
pubmed-article:281556pubmed:dateCreated1979-2-12lld:pubmed
pubmed-article:281556pubmed:abstractTextOn the basis of studies indicating that natural killer (NK) cells of the mouse can selectively kill certain syngenetic, allogeneic, and xenogeneic tumor cells in short-term Cr release assays and that cell lines established in vitro are more sensitive than the corresponding ascites tumor cells passaged in vivo, the kinetics of the modulation to increased sensitivity was studied after in vitro explanation of the A/Sn mouse-derived YAC ascites lymphoma. Sensitivity to NK lysis appeared after 3 weeks of culturing and reached the level of the continuously cultured line after 2 months. With the more sensitive competition assay, a change could be demonstrated as early as 2--24 hours of culture. The expression of the Moloney murine leukemia virus-determined, cell-surface antigen, measured by quantitative absorption with intact cells, increased in parallel with the NK sensitivity. In contrast, the H-2 alloantigen concentration decreased during in vitro culture.lld:pubmed
pubmed-article:281556pubmed:languageenglld:pubmed
pubmed-article:281556pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:281556pubmed:citationSubsetIMlld:pubmed
pubmed-article:281556pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:281556pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:281556pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:281556pubmed:statusMEDLINElld:pubmed
pubmed-article:281556pubmed:monthDeclld:pubmed
pubmed-article:281556pubmed:issn0027-8874lld:pubmed
pubmed-article:281556pubmed:authorpubmed-author:KleinGGlld:pubmed
pubmed-article:281556pubmed:authorpubmed-author:LeeNNlld:pubmed
pubmed-article:281556pubmed:authorpubmed-author:BeckerSSlld:pubmed
pubmed-article:281556pubmed:authorpubmed-author:KiesslingRRlld:pubmed
pubmed-article:281556pubmed:issnTypePrintlld:pubmed
pubmed-article:281556pubmed:volume61lld:pubmed
pubmed-article:281556pubmed:ownerNLMlld:pubmed
pubmed-article:281556pubmed:authorsCompleteYlld:pubmed
pubmed-article:281556pubmed:pagination1495-8lld:pubmed
pubmed-article:281556pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:281556pubmed:meshHeadingpubmed-meshheading:281556-A...lld:pubmed
pubmed-article:281556pubmed:meshHeadingpubmed-meshheading:281556-M...lld:pubmed
pubmed-article:281556pubmed:meshHeadingpubmed-meshheading:281556-F...lld:pubmed
pubmed-article:281556pubmed:meshHeadingpubmed-meshheading:281556-M...lld:pubmed
pubmed-article:281556pubmed:meshHeadingpubmed-meshheading:281556-S...lld:pubmed
pubmed-article:281556pubmed:meshHeadingpubmed-meshheading:281556-L...lld:pubmed
pubmed-article:281556pubmed:meshHeadingpubmed-meshheading:281556-N...lld:pubmed
pubmed-article:281556pubmed:meshHeadingpubmed-meshheading:281556-M...lld:pubmed
pubmed-article:281556pubmed:meshHeadingpubmed-meshheading:281556-C...lld:pubmed
pubmed-article:281556pubmed:meshHeadingpubmed-meshheading:281556-T...lld:pubmed
pubmed-article:281556pubmed:meshHeadingpubmed-meshheading:281556-M...lld:pubmed
pubmed-article:281556pubmed:meshHeadingpubmed-meshheading:281556-A...lld:pubmed
pubmed-article:281556pubmed:meshHeadingpubmed-meshheading:281556-A...lld:pubmed
pubmed-article:281556pubmed:meshHeadingpubmed-meshheading:281556-H...lld:pubmed
pubmed-article:281556pubmed:meshHeadingpubmed-meshheading:281556-A...lld:pubmed
pubmed-article:281556pubmed:meshHeadingpubmed-meshheading:281556-K...lld:pubmed
pubmed-article:281556pubmed:year1978lld:pubmed
pubmed-article:281556pubmed:articleTitleModulation of sensitivity to natural killer cell lysis after in vitro explantation of a mouse lymphoma.lld:pubmed
pubmed-article:281556pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:281556pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:281556lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:281556lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:281556lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:281556lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:281556lld:pubmed